Cargando…
Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: Targeted delivery of the therapeutic payload in an orthotopic brain tumor model
Oncolytic virotherapy is a promising novel therapy for glioblastoma that needs to be optimized before introduced to clinic. The targeting of conditionally replicating adenoviruses (CRAds) can be improved by relying on the tumor tropic properties of neural stem cells (NSCs). Here, we report the chara...
Autores principales: | Thaci, Bart, Ahmed, Atique U., Ulasov, Ilya V., Tobias, Alex L., Han, Yu, Aboody, Karen S., Lesniak, Maciej S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356460/ https://www.ncbi.nlm.nih.gov/pubmed/22555507 http://dx.doi.org/10.1038/cgt.2012.21 |
Ejemplares similares
-
Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions
por: Kim, Janice, et al.
Publicado: (2015) -
Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice
por: Auffinger, Brenda, et al.
Publicado: (2013) -
Enhanced Transduction and Replication of RGD-Fiber Modified Adenovirus in Primary T Cells
por: Sengupta, Sadhak, et al.
Publicado: (2011) -
Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma
por: Dey, Mahua, et al.
Publicado: (2016) -
Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation
por: Thaci, Bart, et al.
Publicado: (2012)